Back
scPharmaceuticals Quote, Financials, Valuation and Earnings
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
27
SCPH
scPharmaceuticals
Last Price:
5.26
Seasonality Move:
-14.35%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.scPharmaceuticals Price Quote
$5.26
-0.17 (-3.13%)
(Updated: September 19, 2024 at 6:55 PM ET)
scPharmaceuticals Key Stats
Sell
27
scPharmaceuticals (SCPH)
is a Sell
Day range:
$5.23 - $5.55
52-week range:
$3.24 - $7.55
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.78
P/B ratio:
29.37%
Volume:
435.7K
Avg. volume:
351.3K
1-year change:
-23.52%
Market cap:
$271.7M
Revenue:
$13.6M
EPS:
$-1.56
How Much Does scPharmaceuticals Make?
-
How Much Are scPharmaceuticals's Sales Annually?
SCPH Revenues are $13.6M -
How Much Profit Does scPharmaceuticals's Make A Year?
SCPH net income is -$54.8M
Is scPharmaceuticals Growing As A Company?
-
What Is scPharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 3.92% -
What Is scPharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
scPharmaceuticals Stock Price Performance
-
Did scPharmaceuticals Stock Go Up Last Month?
scPharmaceuticals share price went up by 4.62% last month -
Did SCPH's Share Price Rise Over The Last Year?
SCPH share price fell by -23.52% over the past 1 year
What Is scPharmaceuticals 52-Week High & Low?
-
What Is scPharmaceuticals’s 52-Week High Share Price?
scPharmaceuticals has traded as high as $7.55 over the past 52 weeks -
What Is scPharmaceuticals’s 52-Week Low Share Price?
scPharmaceuticals has traded as low as $3.24 over the past 52 weeks
scPharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy scPharmaceuticals?
-
How Much Debt Does scPharmaceuticals Have?
Total long term debt quarterly is $40M -
How Much Cash Does scPharmaceuticals Have?
Cash and short term investments quarterly total is $38.5M -
What Is scPharmaceuticals’s Book Value Per Share?
Book value per share is 0.26
Is scPharmaceuticals Cash Flow Positive?
-
What Is SCPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$66.5M -
What Is scPharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $833K -
What Is scPharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $32.9M
scPharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
SCPH return on invested capital is -80.26% -
What Is scPharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -66.11% -
What Is SCPH Return On Equity?
ROE is a measure of profitability and is -165.15%
scPharmaceuticals Earnings Date & Stock Price
-
What Is scPharmaceuticals's Stock Price Today?
A single share of SCPH can be purchased today for 5.43 -
What Is scPharmaceuticals’s Stock Symbol?
scPharmaceuticals trades on the nasdaq under the ticker symbol: SCPH -
When Is scPharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for scPharmaceuticals is scheduled on November 8, 2024 -
When Is SCPH's next ex-dividend date?
scPharmaceuticals's next ex-dividend date is September 20, 2024 -
How To Buy scPharmaceuticals Stock?
You can buy scPharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
scPharmaceuticals Competitors
-
Who Are scPharmaceuticals's Competitors?
Below is a list of companies who compete with scPharmaceuticals or are related in some way:
scPharmaceuticals Dividend Yield
-
What Is SCPH Dividend Yield?
scPharmaceuticals’s dividend yield currently is 0% -
What Is scPharmaceuticals’s Payout Ratio?
scPharmaceuticals’s payout ratio is 0% -
When Did scPharmaceuticals Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is scPharmaceuticals’s Dividend Per Share?
scPharmaceuticals pays a dividend of $0.00 per share
scPharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -6.28% |
| Revenue: | 391.7% | 1.06% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 19.80 |
| Upside from Last Price: | 264.64% |